Učitavanje...
Ticagrelor: molecular discovery to clinical evidence: Ticagrelor: a novel antiplatelet agent
Cardiovascular (CV) deaths are one of the leading cause of death, both in developed and developing countries, with acute coronary syndrome (ACS) accounting for about 50% of all CV deaths. Atherothrombosis formation is the prime reason behind ACS and platelets play a central role in formation of thro...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2012
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3861097/ https://ncbi.nlm.nih.gov/pubmed/23102389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2012.09.002 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|